Patent · US Active

Heterocyclic adenosine receptor antagonists

US12264161B2 · kind B2 · utility

0Cited by
0References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 25, 2023
Grant dateApr 1, 2025
Priority date—
Expiry dateMay 25, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D513/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Heterocyclic compounds useful as antagonists of adenosine receptors, and methods of treatment of diseases using antagonists of adenosine receptors are disclosed herein. Also disclosed herein are pharmaceutical compositions and methods of administration of heterocyclic antagonists of adenosine receptors and processes for producing heterocyclic antagonists of adenosine receptors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.